Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe

CompletedOBSERVATIONAL

Enrollment

2,809

Participants

Timeline

Start Date

April 6, 2016

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions

Venous Thromboembolism

Interventions

DRUG

Edoxaban

Prescribed according to approved label

Trial Locations (1)

International Clinical Research GmbH, Germering

All Listed Sponsors

lead

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

INDUSTRY

NCT02943993 - Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe | Biotech Hunter | Biotech Hunter